Valneva SE Logo

Valneva SE

Specialty vaccine company developing and commercializing vaccines for infectious diseases.

VLA | PA

Overview

Corporate Details

ISIN(s):
AT0000A10B99 (+3 more)
LEI:
969500DIVIP5VKNW4948
Country:
France
Address:
6 RUE ALAIN BOMBARD, 44800 SAINT-HERBLAIN

Description

Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet medical needs. The company has leveraged its expertise to commercialize three vaccines, including a single-shot vaccine for chikungunya. Its research and development pipeline features a broad range of vaccine candidates, including those targeting Lyme disease, Shigella, and Zika.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2013-08-28 09:30
Rapport Financier Semestriel
French 947.1 KB
2013-08-28 09:30
20130828ValnevaH1ResultsFR
French 508.7 KB
2013-08-28 09:30
20130828ValnevaH1ResultsEN
English 378.2 KB
2013-08-12 20:40
20130812MajidFRPR
French 196.4 KB
2013-08-12 20:40
20130812MajidENPR
English 195.9 KB
2013-08-06 18:48
VALNEVA ACTIONS ET DROITS DE VOTE 2013
French 138.9 KB
2013-07-22 18:40
20130722BEValnevaPREN
English 423.6 KB
2013-07-22 18:40
20130722BEValnevaPRFR
French 382.0 KB
2013-07-19 19:00
VALNEVA ACTIONS ET DROITS DE VOTE JUILLET 2013
French 138.1 KB
2013-07-16 09:30
20130716ENValnevaBIVPR
English 197.0 KB
2013-07-16 09:30
20130716FRValnevaBIVPR
French 211.1 KB
2013-07-05 18:07
VALNEVA : Contrat de liquidité Bilan semestriel
French 160.2 KB
2013-07-05 17:55
VALNEVA :DECLARATIONS ACTIONS ET DROITS DE VOTE
French 133.5 KB
2013-07-04 08:07 English 11.3 KB
2013-07-04 08:07 German 11.3 KB

Automate Your Workflow. Get a real-time feed of all Valneva SE filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Valneva SE

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Valneva SE via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-03-18 N/A Other Buy 44,222 N/A
2024-01-03 N/A Other Other 34,802 N/A
2023-06-20 N/A Other Sell 192,547 1,406,228.50 EUR
2023-06-19 N/A Other Sell 30,661 209,629.26 EUR
2023-06-16 N/A Other Sell 85,589 582,493.06 EUR
2023-06-15 N/A Other Sell 28,179 189,503.78 EUR
2023-06-14 N/A Other Sell 228,951 1,519,914.11 EUR
2023-06-13 N/A Other Sell 29,401 187,922.37 EUR
2023-06-12 N/A Other Sell 117,854 733,782.57 EUR
2023-05-10 N/A Other Buy 87,523 N/A

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.